-
Suzlon Energy
74.30 86.04(%) -
Reliance Power
60.50 60.50(%) -
Swiggy
338.00 617.00(%) -
Mazagon Dock
3,450.00 1,200.00(%) -
Eternal Ltd
243.00 304.50(%) -
MMTC
88.20 131.88(%) -
Garden Reach Sh.
2,926.85 1,148.10(%) -
Waaree Energies
2,956.60 1,808.65(%) -
Indian Energy Ex
203.20 244.35(%) -
Bharat Dynamics
2,096.00 2,096.00(%) -
Engineers India
239.00 304.00(%) -
NBCC
126.41 139.83(%) -
IFCI
66.71 35.67(%) -
Muthoot Finance
2,241.75 2,444.65(%) -
HDFC Bank
1,948.60 1,977.95(%) -
LMW
16,640.85 13,456.85(%) -
Hind.Aeronautics
4,962.00 3,045.95(%) -
Pidilite Inds.
3,127.25 3,414.40(%) -
Infosys
1,555.10 1,307.10(%) -
Ola Electric
48.07 45.55(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Gland Pharma Ltd Pharmaceuticals - Indian - Formulations
- MNC Associate
- BSE Code : 14546.0
- ISIN : INE068V01023
-
Today’s Low
1,570.00 -
Today’s High
1,596.90

-
Open
1,578.20 -
Perv Close
1,578.20 -
52W Low
1,277.80 -
52W High
2,220.95
Key Indicators
-
P/E(TTM)
24.01
-
Mar.Cap (₹Cr.)
26,173.20
-
Div & Yield %
1.13
-
Book Value(₹)
592.09
-
Debt-Equity Ratio
0.66
-
AGM Date
30-May-2025
-
EPS
66.14
-
P/E Ratio
24.01
Financials Ratios
-
Debt-Equity Ratio
0.02
-
Mar.Cap (₹Cr.)
26,173.20
-
RONW (%)
9.26
-
ROCE (%)
13.44
Score Board
-
Equity (₹ in Cr.)
16.48
-
BV (₹)
592.10
-
Sales( ₹ in Cr.)
4,116.15
-
NP (in Cr.)
1,089.75
-
NP Var(%)
4.0
-
Div%
1800.0
-
CPS (₹)
76.40
-
EPS (₹)
66.10
-
Traded Value (₹ in Lakhs)
26,169.09
-
52 Week High
2,220.95
-
52 Week Low
1,277.80
-
Price BSE
1588.0
-
Price NSE
1,589.00
-
Market Capital( in Cr.)
26,169.09
-
P/C Ratio
20.80
-
P/E Ratio
24.00
-
Price Vs.BV
66.10
-
21-May-2025( 03:23)
Corporate News - Gland... - Gland Pharma announced that th...
-
21-May-2025( 07:37)
Results - Announcements - Gland... - Net profit of Gland Pharma dec...
-
20-May-2025( 09:08)
Corporate News - Board... - Gland Pharma announced that th...
-
07-May-2025( 11:32)
Corporate News - Gland... - Gland Pharma will hold a meeti...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 4,167.43 | 3,616.53 | 4,400.71 | 3,462.88 | 2,633.24 | 2,044.20 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 4,167.43 | 3,616.53 | 4,400.71 | 3,462.88 | 2,633.24 | 2,044.20 |
Other Income | 166.67 | 240.46 | 223.94 | 134.78 | 139.17 | 85.56 |
Stock Adjustments | -87.43 | 46.92 | -36.69 | 273.49 | 6.90 | 114.15 |
Total Income | 4,246.67 | 3,903.91 | 4,587.96 | 3,871.15 | 2,779.31 | 2,243.91 |
EXPENDITURE : | ||||||
Raw Materials | 1,732.88 | 1,732.34 | 2,072.53 | 1,765.36 | 1,108.93 | 971.18 |
Power and Fuel Cost | 117.20 | 124.84 | 95.05 | 74.59 | 78.50 | 74.03 |
Employee Cost | 409.95 | 399.70 | 338.57 | 311.36 | 277.66 | 222.95 |
Other Manufacturing Expenses | 186.92 | 153.84 | 137.19 | 130.84 | 102.23 | 85.50 |
Selling and Administration Expenses | 175.97 | 189.65 | 177.43 | 128.44 | 98.54 | 82.52 |
Miscellaneous Expenses | 48.31 | 100.99 | 32.61 | 23.51 | 18.82 | 35.86 |
Employee Benefit Expenses | 409.95 | 399.70 | 338.57 | 311.36 | 277.66 | 222.95 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 2,671.22 | 2,701.35 | 2,853.38 | 2,434.10 | 1,684.68 | 1,472.05 |
Operating Profit | 1,575.44 | 1,202.55 | 1,734.58 | 1,437.04 | 1,094.63 | 771.88 |
Interest | 7.84 | 7.41 | 5.24 | 3.41 | 7.18 | 3.56 |
Gross Profit | 1,567.60 | 1,195.14 | 1,729.34 | 1,433.63 | 1,087.45 | 768.32 |
Depreciation | 162.11 | 146.74 | 110.30 | 98.78 | 94.59 | 81.96 |
Profit Before Tax | 1,405.49 | 1,048.40 | 1,619.04 | 1,334.85 | 992.86 | 686.36 |
Current Tax | 337.49 | 275.38 | 392.88 | 337.73 | 251.83 | 222.45 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 24.68 | -2.80 | 14.01 | 0.12 | -31.82 | 12.00 |
Reported Net Profit | 1,043.33 | 775.83 | 1,212.16 | 997.01 | 772.86 | 451.91 |
Extraordinary Items | -0.39 | -39.55 | 3.22 | 0.02 | 12.99 | -13.15 |
Adjusted Net Profit | 1,043.72 | 815.38 | 1,208.94 | 996.99 | 759.87 | 465.06 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 6,010.70 | 5,234.88 | 4,022.72 | 3,025.72 | 2,252.86 | 1,800.95 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | 7,054.03 | 6,010.70 | 5,234.88 | 4,022.72 | 3,025.72 | 2,252.86 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 2,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 20.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | 63.34 | 47.11 | 73.78 | 60.95 | 49.88 | 291.65 |
Earnings Per Share(Adj)-Unit Curr | 63.34 | 47.11 | 73.78 | 60.95 | - | - |
Book Value | 546.13 | 482.90 | 435.68 | 360.86 | 235.32 | 1,847.12 |
Book Value(Adj)-Unit Curr | 546.13 | 482.90 | 435.68 | 360.86 | - | - |